Skip to main content

Table 4 Concentrations of anti-Hsp60 and anti-Hsp65 IgG antibodies in group of women with ovarian cancer depending on histopathological type of tumor and in control group

From: Antibodies against Hsp60 and Hsp65 in the sera of women with ovarian cancer

 

Ovarian cancer

Controls

Adenocarcinoma papillare serosum

Adenocarcinoma mucinosum

Adenocarcinoma endometrioides

n = 80

n = 82

n = 44

n = 23

Anti-Hsp60 (AU/ml)

104,17 ± 159,89

82,94 ± 82,87

77,77 ± 83,41

62,42 ± 33,93

(mean ± SD)

  % of positive results

26%*

19%

21%

10%

  (> 90 percentile for control group)

p = 0.0075

p = 0.1476

p = 0.1535

Anti-Hsp65 (AU/ml)

106,41 ± 217,07

78,64 ± 85,73

85,32 ± 92,47

56,35 ± 35,57

(mean ± SD)

  % of positive results

21,5%*

15%

29%*

10%

  (> 90 percentile for control group)

p = 0.0424

p = 0.3972

p = 0.0200

  1. *p < 0.05 in group of women with ovarian cancer compared to control group.